Purchase Order 75D30123P17945
Award Date 9/11/23
Potential Completion Date 11/2/23
Potential Value $177K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $27,274.50 firm fixed price purchase order to Illumina, Inc. of San Diego, California for lab supplies and MiSeq reagent kits. The contract has no set-aside designation and requires completion by October 14, 2022. The MiSeq reagent kits will support the CDC's genomic sequencing work to advance public health goals such as disease surveillance and outbreak response. Illumina will deliver the...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $68,541 purchase order to provide LLUMINA MISEQ SYSTEM REAGENTS. The firm fixed price contract has a period of performance from July 3, 2023 through August 19, 2023. Illumina will deliver its Illumina MiSeq System reagents to support the CDC's genomics and sequencing programs. No subcontractors or set aside designations were identified. The contract award utilizes the...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $19,502 purchase order to Illumina, Inc. for ISEQ 100NGS kits. The firm fixed price contract has a period of performance of one day, September 6, 2023. The place of performance will be Illumina's location in Atlanta, Georgia. The CDC is likely procuring the next generation sequencing kits to support genomic surveillance efforts within its broader infectious disease programs. No...
- The Centers for Disease Control and Prevention (CDC) awarded Illumina, Inc. a $160,535.84 firm fixed price purchase order for reagents. The CDC, part of the Department of Health and Human Services, will utilize the reagents in Pittsburgh, Pennsylvania as part of its efforts to advance public health. Illumina will deliver the products from its facilities in San Diego, California by September 30, 2023 to support the CDC's disease prevention and health promotion activities. No set aside designation...
- The CDC Pittsburgh awarded a $29,595.03 firm fixed-price purchase order to Illumina, Inc. on August 9, 2024, for NextEra XT Library Preparation kits and related reagent supplies required for the agency's validated MiSeq Next-Generation Sequencing (NGS) assay. This assay supports the identification of HIV genetic mutations associated with drug resistance—a critical capability for HIV surveillance and treatment optimization. The contract, which carries no set-aside designation, will be performed...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $23,371 firm fixed-price purchase order to Illumina, Inc. for the ISEQ 100 System on August 24, 2021. The contract, which was completed by September 30, 2023, was issued without a set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing technology. The ISEQ 100 is a compact, entry-level sequencing instrument designed for targeted genomic analysis applications, supporting the CDC's...
- The Centers for Disease Control and Prevention (CDC) awarded a $7,303.60 firm fixed price purchase order to Illumina, Inc. to provide supplies in support of the agency's programs. The contract has a period of performance from August 14, 2023 through September 10, 2023 and will be performed in San Diego, California. As the prime contractor, Illumina will deliver supplies to the CDC's Pittsburgh location. No major subcontractors or set aside designations were identified. The funding supports the...
- This firm fixed price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of MiSeq Sequencing Kits. The total ceiling value of the contract is $184,230.65, with a completion date of October 10, 2024. The contract is not set-aside. The MiSeq Sequencing Kits are being procured to support the CDC's surveillance, outbreak, and research activities for strain characterization of streptococcal pathogens. Obtaining...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $233,447.32 firm fixed price contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, which has no set-aside designation, is for MISEQ SUPPORT SERVICES with a period of performance ending on March 31, 2028. Illumina, which has a history of providing sequencing systems, reagents, and related services to federal agencies, will...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $46,172.80 firm fixed price purchase order for Illumina reagents. The place of performance will be Illumina's facility located in Chamblee, Georgia. The period of performance is from February 7, 2023 through August 15, 2023. CDC Pittsburgh is likely procuring the reagents to support its genomic sequencing and bioinformatics programs that help public health agencies detect,...